The VitaSIRO solo™ SARS-CoV-2/Flu/RSV Assay provides an efficient on-site solution for respiratory infection diagnosis, eliminating the need to ship samples to central labs and significantly reducing both costs and turnaround time. With a fully automated sample-to-result process, the VitaSIRO solo™ Instrument processes nasal and nasopharyngeal swabs, delivering reliable results for SARS-CoV-2, influenza A/B, and RSV within approximately 40 minutes.
Usability
Performance
Collect sample
Transfer the sample
to the cartridge
Results reported in
40 minutes
Collect sample
Lyse the sample
thoroughly for 15 times
Transfer the sample
Results reported in
20 minutes
Catalog No.
PCRAD1102/PCRAD1112
Technology
Real-Time PCR + Fluorescence Spectrum Detection
Quantity
12 cartridge/box
Targets
SARS-CoV-2, Flu A/B, RSV A, RSV B
Specimen
Nasal Swab + Nasopharyngeal Swab
Hands-on Time
< 1 minute
Turnaround Time
40 mins
Kit Storage
5~25°C
Focusing on research and development of revolutionary diagnostic technologies since 2011, Credo Diagnostics develops, manufactures, and commercializes accurate, rapid, and affordable molecular diagnostic solutions at the Point-Of-Care testing.
© 2023 | Credo Diagnostics Biomedical Pte. Ltd.